196 related articles for article (PubMed ID: 38649221)
1. Pathophysiology of Hepatorenal Syndrome.
Velez JCQ; Latt N; Rodby RA
Adv Kidney Dis Health; 2024 Mar; 31(2):87-99. PubMed ID: 38649221
[TBL] [Abstract][Full Text] [Related]
2. The kidney in cirrhosis with portal hypertension.
Olteanu D; Lupu D
J Med Life; 2010; 3(2):175-7. PubMed ID: 20968204
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of ascites in cirrhosis and portal hypertension.
Heneghan MA; Harrison PM
Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
[TBL] [Abstract][Full Text] [Related]
5. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
Solà E; Ginès P
Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
[TBL] [Abstract][Full Text] [Related]
7. New Developments in Hepatorenal Syndrome.
Mindikoglu AL; Pappas SC
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):162-177.e1. PubMed ID: 28602971
[TBL] [Abstract][Full Text] [Related]
8. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
[TBL] [Abstract][Full Text] [Related]
10. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology and treatment of ascites and the hepatorenal syndrome.
Gentilini P; Laffi G
Baillieres Clin Gastroenterol; 1992 Sep; 6(3):581-607. PubMed ID: 1421601
[TBL] [Abstract][Full Text] [Related]
12. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
13. [Physiopathology of refractory ascites and the hepatorenal syndrome].
Arroyo V
Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
[No Abstract] [Full Text] [Related]
14. Pathophysiology of Hepatorenal Syndrome - Acute Kidney Injury.
Adebayo D; Wong F
Clin Gastroenterol Hepatol; 2023 Sep; 21(10S):S1-S10. PubMed ID: 37625861
[TBL] [Abstract][Full Text] [Related]
15. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
Møller S; Henriksen JH
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
[TBL] [Abstract][Full Text] [Related]
16. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
17. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites.
Téllez L; Ibáñez-Samaniego L; Pérez Del Villar C; Yotti R; Martínez J; Carrión L; Rodríguez de Santiago E; Rivera M; González-Mansilla A; Pastor Ó; Bermejo J; Bañares R; Albillos A
J Hepatol; 2020 Dec; 73(6):1404-1414. PubMed ID: 32446716
[TBL] [Abstract][Full Text] [Related]
18. Hepatorenal syndrome.
Kramer L; Hörl WH
Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
[TBL] [Abstract][Full Text] [Related]
19. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
20. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.
Møller S; Krag A; Bendtsen F
Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
